Their Royal Highnesses Crown Prince Alexander II and Crown Princess Katherine hosted today at the White Palace a symposium on the occasion of the World Asthma Day organized by AstraZeneca, a British-Swedish multinational biopharmaceutical company with Headquarters in London, United Kingdom.
His Royal Highness Crown Prince Alexander II welcomed the guests and emphasised: “Since my family and I returned to Serbia, thirteen years ago, we have invested a lot of effort to help our country’s health care system.
The humanitarian Foundation of my wife especially excelled in that respect, strongly supporting expert training of our health are professionals. It is very important that they keep up to date with the latest advances in medicine and pharmacy, and to share information with their colleagues from around the world.”
At the symposium that gathered over 100 medical doctors and pharmacologists, the moderator was Prof. Dr Branislava Milenkovic, and key speakers were Dr Dejan Dimic, Dr Vesna Dopudja Pantic and Ass. Dr Vladimir Zugic.
AstraZeneca is the world’s seventh-largest pharmaceutical company and has operations in over 100 countries. AstraZeneca has a portfolio of products for major disease areas including cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation. AstraZeneca in Serbia is supporting a project of psycho-oncology counselling at the Clinic for Gynecology of Clinical Centre of Serbia, that has been supported by HRH Crown Princess Katherine Humanitarian Foundation.